Hospira Hits 52-Week Low on Slashed Forecast

NEW YORK ( TheStreet) -- Hospira ( HSP) shares were falling almost 20% after the drugmaker cut its 2011 earnings forecast.

Hospira said it expects 2011 adjusted earnings of $2.95 to $3.05 a share. Over the summer, the company said it expected earnings of as much as $4 a share.

"While recently launched product sales continue to drive top-line growth, we were extremely disappointed in the third quarter by developments related to our quality-improvement initiatives that resulted in a significant slowdown of production and an associated impact on our operating performance," said F. Michael Ball, Hospira's CEO, in a statement.

The company said it expects third-quarter adjusted earnings of 66 cents a share on sales of $977 million, far lower than analysts' estimates.

Hospira blamed the slowdown on quality actions it took at its manufacturing plant in Rocky Mount, N.C., in response to a Food and Drug Administration warning letter in 2010.

Hospira shares were down $7.21, or $19.3%, to $30.15. The stock touched a 52-week low of $29.16 earlier Tuesday. Its 52-week high is $60.49.

-- Written by Joseph Woelfel

>To contact the writer of this article, click here: Joseph Woelfel

>To submit a news tip, send an email to: tips@thestreet.com.

More from Stocks

General Electric's Boot From the Dow: Is This as Bad as It Can Get?

General Electric's Boot From the Dow: Is This as Bad as It Can Get?

News From Starbucks and General Electric Leaves Their Investors Up in Arms

News From Starbucks and General Electric Leaves Their Investors Up in Arms

Facebook Messenger Could Bring in Billions of Dollars -- Here's How

Facebook Messenger Could Bring in Billions of Dollars -- Here's How

How to Invest in Cannabis - In Its Many Forms

How to Invest in Cannabis - In Its Many Forms

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now